APP and Alzheimer disease: Moreover, IL-33 signalling shown to reduce synaptic impairment and subsequent memory deficits in APP/PS1 mice was impaired in lipopolysaccharide-primed and Aβ-stimulated monocytes from patients with AD dementia [275], further suggesting that an altered monocyte phenotype may contribute to AD pathology.